A detailed history of Foster & Motley Inc transactions in Novartis Ag stock. As of the latest transaction made, Foster & Motley Inc holds 18,938 shares of NVS stock, worth $1.86 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
18,938
Previous 16,138 17.35%
Holding current value
$1.86 Million
Previous $1.72 Million 26.78%
% of portfolio
0.14%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$106.13 - $120.89 $297,164 - $338,492
2,800 Added 17.35%
18,938 $2.18 Million
Q2 2024

Aug 02, 2024

BUY
$92.57 - $107.37 $331,400 - $384,384
3,580 Added 28.51%
16,138 $1.72 Million
Q1 2024

Apr 18, 2024

BUY
$95.27 - $108.47 $296,289 - $337,341
3,110 Added 32.92%
12,558 $1.22 Million
Q4 2023

Feb 01, 2024

BUY
$92.27 - $101.54 $402,112 - $442,511
4,358 Added 85.62%
9,448 $954,000
Q3 2023

Oct 24, 2023

BUY
$94.73 - $105.13 $138,968 - $154,225
1,467 Added 40.49%
5,090 $518,000
Q1 2023

May 09, 2023

SELL
$80.03 - $92.81 $4,161 - $4,826
-52 Reduced 1.41%
3,623 $333,000
Q4 2022

Feb 09, 2023

BUY
$75.55 - $92.52 $33,997 - $41,634
450 Added 13.95%
3,675 $333,000
Q3 2022

Nov 04, 2022

SELL
$74.61 - $87.26 $13,429 - $15,706
-180 Reduced 5.29%
3,225 $245,000
Q1 2022

Apr 28, 2022

SELL
$80.11 - $90.62 $64,007 - $72,405
-799 Reduced 19.01%
3,405 $299,000
Q4 2021

Jan 25, 2022

SELL
$79.7 - $88.13 $211,205 - $233,544
-2,650 Reduced 38.66%
4,204 $368,000
Q3 2021

Oct 29, 2021

BUY
$81.78 - $95.14 $66,487 - $77,348
813 Added 13.46%
6,854 $561,000
Q2 2021

Jul 20, 2021

SELL
$85.24 - $94.15 $27,106 - $29,939
-318 Reduced 5.0%
6,041 $551,000
Q1 2021

Apr 26, 2021

BUY
$83.5 - $98.47 $530,976 - $626,170
6,359 New
6,359 $544,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.